Literature DB >> 11170761

Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration.

L Thomas1, J Y Maillard, R J Lambert, A D Russell.   

Abstract

Stable resistance in Pseudomonas aeruginosa NCIMB 10421 was obtained by step-wise exposure to gradually increasing concentrations of chlorhexidine diacetate (CHX). Repeated exposure to a proposed "residual" (sub-MIC) concentration of CHX also created stable resistance. Resistance was also developed by a single exposure to the "residual" concentration of CHX, but this was unstable. Similar experiments with Escherichia coli and CHX or cetylpyridinium chloride resulted in no significant increase in resistance. Antibiotic susceptibility profiles of the CHX-resistant P. aeruginosa cultures showed no cross-resistance, although some of the cultures were resistant to benzalkonium chloride. Copyright 2000 The Hospital Infection Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11170761     DOI: 10.1053/jhin.2000.0851

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  33 in total

1.  Development of a protocol for predicting bacterial resistance to microbicides.

Authors:  Laura Knapp; Alejandro Amézquita; Peter McClure; Sara Stewart; Jean-Yves Maillard
Journal:  Appl Environ Microbiol       Date:  2015-01-30       Impact factor: 4.792

2.  In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources.

Authors:  Matthias Napp; Georg Daeschlein; Sebastian von Podewils; Peter Hinz; Steffen Emmert; Hermann Haase; Romy Spitzmueller; Denis Gümbel; Richard Kasch; Michael Jünger
Journal:  Infection       Date:  2016-03-07       Impact factor: 3.553

3.  Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide In Vitro and In Vivo.

Authors:  A Renzoni; E Von Dach; C Landelle; S M Diene; C Manzano; R Gonzales; W Abdelhady; C P Randall; E J Bonetti; D Baud; A J O'Neill; A Bayer; A Cherkaoui; J Schrenzel; S Harbarth; P François
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

4.  Skin bacteria after chlorhexidine exposure-is there a difference in response to human beta-Defensin-3?

Authors:  M Reichel; A Heisig; P Heisig; G Kampf
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-27       Impact factor: 3.267

5.  Pseudomonas aeruginosa PAO1 adapted to 2-phenoxyethanol shows cross-resistance to dissimilar biocides and increased susceptibility to antibiotics.

Authors:  S M A Abdel Malek; Y R Badran
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

6.  Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride.

Authors:  Jeong Myeong Kim; Youngbeom Ahn; John J LiPuma; David Hussong; Carl E Cerniglia
Journal:  J Ind Microbiol Biotechnol       Date:  2015-03-21       Impact factor: 3.346

Review 7.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Study of the hormetic effect of disinfectants chlorhexidine, povidone iodine and benzalkonium chloride.

Authors:  L Morales-Fernández; M Fernández-Crehuet; M Espigares; E Moreno; E Espigares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-27       Impact factor: 3.267

10.  Microbiological evaluation of the efficacy of two new biodetergents on multidrug-resistant nosocomial pathogens.

Authors:  Giorgio Liguori; Maria Bagattini; Francesca Gallè; Valeria Quartucci; Valeria Di Onofrio; Mario Negrone; Maria Triassi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-12-16       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.